LONDON: The UK drug regulator said on Saturday it has approved an updated COVID-19 jab by Pfizer/BioNtech targeting the original virus and a subvariant ahead of an autumn booster drive.
So-called “bivalent” jabs work for both the original virus that emerged in the Chinese city of Wuhan in 2019 and the BA.1 subvariant omicron,
UK medicines and Health care Product Regulatory Agency (MHRA) approved pfizer The jab as a booster for people 12 years of age and older after “careful review of the evidence.”
The UK regulator last month approved a similar bivalent vaccine by Moderna, becoming the first country to do so.
MHRA chief executive June Raine said: “I am pleased to announce that we now have the second approved vaccine for the UK Autumn Booster Programme.”
National Health Service A new booster rollout will begin in England and Scotland on Monday, beginning with care home residents and eventually inviting everyone over 50.
Other UK territories in Wales and Northern Ireland are also launching similar campaigns.
BBC reported on Saturday that the Moderna biconvex shot would be offered first, but added that the UK did not have enough supplies to cover everyone over 50.
The European Union and the United States have recently authorized updated versions of Pfizer Vaccine and Moderna Vaccine.
So-called “bivalent” jabs work for both the original virus that emerged in the Chinese city of Wuhan in 2019 and the BA.1 subvariant omicron,
UK medicines and Health care Product Regulatory Agency (MHRA) approved pfizer The jab as a booster for people 12 years of age and older after “careful review of the evidence.”
The UK regulator last month approved a similar bivalent vaccine by Moderna, becoming the first country to do so.
MHRA chief executive June Raine said: “I am pleased to announce that we now have the second approved vaccine for the UK Autumn Booster Programme.”
National Health Service A new booster rollout will begin in England and Scotland on Monday, beginning with care home residents and eventually inviting everyone over 50.
Other UK territories in Wales and Northern Ireland are also launching similar campaigns.
BBC reported on Saturday that the Moderna biconvex shot would be offered first, but added that the UK did not have enough supplies to cover everyone over 50.
The European Union and the United States have recently authorized updated versions of Pfizer Vaccine and Moderna Vaccine.